Syndecan-2 regulates PAD2 to exert antifibrotic effects on RA-ILD fibroblasts

Konstantin Tsoyi(University of Maryland, Baltimore), Iván O. Rosas(Brigham and Women's Hospital), Tracy J. Doyle(Brigham and Women's Hospital), Kevin Xiong(Brigham and Women's Hospital), Lindsay J. Celada(Vanderbilt University), Souheil El‐Chemaly(AVEO Oncology (United States)), Anthony J. Esposito(Brigham and Women's Hospital), Mark A. Perrella(Brigham and Women's Hospital), I‐Cheng Ho(Brigham and Women's Hospital), Stefan W. Ryter(University of Pittsburgh Medical Center), F. Poli, R. Bowen(Baylor College of Medicine), Bo Sun(Brigham and Women's Hospital), Xiaoliang Liang(Baylor College of Medicine), Freddy Romero(Baylor College of Medicine), Matthew J. Robertson(Baylor College of Medicine), Christine Beeton(Baylor College of Medicine), Sarah Chu(Brigham and Women's Hospital), Rafael Cardenas(Baylor College of Medicine)
Scientific Reports
February 18, 2022
Cited by 16


Related Papers